Sofinnova Investments’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-327,618
| Closed | -$20.9M | – | 71 |
|
|
2025
Q1 | $20.9M | Sell |
327,618
-101,153
| -24% | -$6.46M | 1.37% | 23 |
|
|
2024
Q4 | $52.1M | Buy |
+428,771
| New | +$52.1M | 3.8% | 6 |
|
|
2024
Q3 | – | Sell |
-195,852
| Closed | -$30.9M | – | 80 |
|
|
2024
Q2 | $30.9M | Sell |
195,852
-31,636
| -14% | -$5M | 1.61% | 19 |
|
|
2024
Q1 | $29.5M | Buy |
+227,488
| New | +$29.5M | 1.64% | 24 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 70 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 62 |
|
|
2023
Q2 | – | Sell |
-119,065
| Closed | -$16.4M | – | 58 |
|
|
2023
Q1 | $16.4M | Sell |
119,065
-128,890
| -52% | -$17.8M | 1.05% | 24 |
|
|
2022
Q4 | $32.1M | Buy |
247,955
+106,515
| +75% | +$13.8M | 1.91% | 14 |
|
|
2022
Q3 | $15.6M | Buy |
141,440
+10,195
| +8% | +$1.13M | 0.91% | 19 |
|
|
2022
Q2 | $9.84M | Buy |
131,245
+42,365
| +48% | +$3.18M | 0.82% | 26 |
|
|
2022
Q1 | $6.94M | Sell |
88,880
-31,852
| -26% | -$2.49M | 0.53% | 38 |
|
|
2021
Q4 | $10.9M | Sell |
120,732
-36,547
| -23% | -$3.29M | 0.64% | 38 |
|
|
2021
Q3 | $14.5M | Sell |
157,279
-141,221
| -47% | -$13.1M | 0.86% | 25 |
|
|
2021
Q2 | $23.2M | Buy |
+298,500
| New | +$23.2M | 1.34% | 17 |
|
|
2021
Q1 | – | Sell |
-51,848
| Closed | -$8.84M | – | 73 |
|
|
2020
Q4 | $8.84M | Buy |
+51,848
| New | +$8.84M | 0.53% | 35 |
|
|
2020
Q2 | – | Sell |
-101,603
| Closed | -$9.94M | – | 82 |
|
|
2020
Q1 | $9.94M | Buy |
101,603
+13,785
| +16% | +$1.35M | 0.92% | 23 |
|
|
2019
Q4 | $11.3M | Sell |
87,818
-18,596
| -17% | -$2.4M | 0.82% | 26 |
|
|
2019
Q3 | $8.02M | Buy |
+106,414
| New | +$8.02M | 0.72% | 29 |
|
|
2019
Q1 | – | Sell |
-48,894
| Closed | -$5.34M | – | 69 |
|
|
2018
Q4 | $5.34M | Buy |
48,894
+18,979
| +63% | +$2.07M | 0.66% | 31 |
|
|
2018
Q3 | $4.83M | Sell |
29,915
-18,485
| -38% | -$2.99M | 0.43% | 38 |
|
|
2018
Q2 | $6.4M | Buy |
+48,400
| New | +$6.4M | 0.72% | 27 |
|